Hematopoietic Stem Cell TransplantationREMM-HIITNCT06953648
Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplant
A study testing High Intensity Interval Training in people with Hematopoietic Stem Cell Transplantation and Cardiorespiratory Fitness, run by University of Kansas Medical Center at 3 sites in United States.
Trial summary
The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and physical function for patients planning to undergo stem cell transplantation. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Hematopoietic Stem Cell Transplantation, Cardiorespiratory Fitness
- What is being tested?
- High Intensity Interval Training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 126 participants
- Where
- 3 sitesUnited States
- Study dates
- May 2025to Mar 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Plan to undergo allogeneic hematopoietic stem cell transplant in 4-12 weeks after enrollment on this study.
- Age 18-80 years
- Able to read/write English (as many participant-reported outcome measures lack validated translations in other languages)
Who cannot join
- Unable or unwilling to follow coaching
- Functional impairment resulting in inability to exercise
- Any absolute contraindications to exercise:
- recent (<6 months) acute cardiac event;
- unstable angina;
- uncontrolled dysrhythmias causing symptoms;
Show all 11Show fewer
- symptomatic aortic stenosis;
- uncontrolled symptomatic heart failure;
- acute pulmonary embolus;
- acute myocarditis or pericarditis;
- suspected or known dissecting aneurysm
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States3 sites
Duke University
Durham, North Carolina, 27705
Amy Pastva, MD, 919-681-4380, amy.pastva@duke.edu
Amy Pastva, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030
Ajay Sheshadri, MD, 713-563-1987, asheshadri@mdanderson.org
Ajay Sheshadri, MD
University of Kansas Cancer Center
Kansas City, Kansas, 66160
Anthony Sung, MD, 913-588-6030, asung2@kumc.edu
Anthony Sung, MD
About this study
Official title: Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)
The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and physical function for patients planning to undergo stem cell transplantation. The main questions it aims to answer are:
Is there a change in the participant's cardiorespiratory fitness level? Is there a change in the participant's physical function?
Read more
Researchers will compare the REMM-HIIT program to a control group of participants who do not take part in the training program to see if REMM-HIIT helps improve stem cell transplantation outcomes.
Participants will:
- Complete cardiopulmonary exercise testing (CPET) 4 times during the study
- Do basic tests to measure physical function 6 times during the study
- Answer questions about their life and how they are feeling 6 times during the study
- Wear a device to keep track of step counts and heart rate daily
- Keep a log of every time they exercise throughout the study
- Optionally, provide blood and stool samples 6 times during the study
Read the detailed description
Each year in the U.S., approximately 8,000 patients undergo allogeneic hematopoietic stem cell transplantation (HCT) as a potentially curative therapy for leukemias, lymphomas, and other hematologic malignancies. However, treatment-related mortality (TRM) is significant, ranging from 10-30%. Moreover, survivors of HCT often face significant physical, psychological, and social challenges post-treatment, leading to a substantial decrease in quality of life (QOL). Outcomes are closely linked to pre-HCT physical activity and function. For example, patients with worse pre-HCT physical function and capacity have markedly lower one-year survival rates (50% vs. 83%). In contrast, every 50-meter increase in pre-HCT six-minute walk distance (6MWD) correlates with a 9% reduction in relative risk for mortality.
Cardiorespiratory fitness (CRF) is a crucial indicator of physical capacity, reflecting the integrated functioning of the heart, lungs, skeletal muscle, adipose tissue, pancreas, liver and adrenal tissues. While CRF naturally declines with age, this decline is notably accelerated by cancer and its treatments, with cancer patients' average CRF levels comparable to individuals 20-30 years older. Importantly, patients with low pre-HCT CRF (VO2peak <16 mL/kg/min) are at much higher risk of TRM (hazard ratio 6.70), even after accounting for other risk factors. This underscores the critical need for interventions to improve CRF prior to HCT to enhance survival and post-treatment quality of life.
It is well established that patients with better pre-HCT physical function tend to have better post-HCT outcomes. The critical question, however, is whether enhancing fitness pre-HCT can improve post-HCT outcomes. Animal studies provide optimism: exercise training in a murine model pre-HCT associated with improved survival, possibly through immune-mediated pathways. Yet, research exploring the impact of pre-HCT exercise on human post-HCT outcomes remains limited. Small studies have linked pre-HCT improvements in physical function with better survival, and preliminary results from a randomized controlled trial suggest that exercise during HCT may reduce mortality. However, a recent large (n=711) randomized Blood and Marrow Transplant Clinical Trials Network study of self-directed exercise and stress management during HCT did not show a significant benefit in outcomes. Study investigators suggested several reasons for this lack of effect, including timing of intervention (peri-HCT rather than pre-HCT), low intensity rather than high intensity exercise, and low engagement in the self-directed program.
To address prior study limitations, the investigators developed the REMM-HIIT program, focusing on pre-HCT intervention, high-intensity interval training (HIIT), and a mobile health (mHealth) platform to support participant engagement. This program, supported by the National Institute of Aging and the Duke Claude D. Pepper Older Americans Independence Center, was piloted in a successful phase 1 study of Remotely Monitored, Mobile health-supported, pre-HCT High Intensity Interval Training (REMM-HIIT). In this feasibility study, participants underwent baseline cardiopulmonary exercise testing (CPET) to ensure cardiac safety and to measure maximal cardiorespiratory fitness (VO2peak). The heart rate (HR) at VO2peak was used to personalize the high and low intensity interval goals. Participants were equipped with an iPhone and Garmin Watch for remote monitoring and exercised three times a week at home, with the first session and subsequent sessions as needed monitored remotely by the coach via videoconference. This approach ensured continuous support and maximized participant engagement while allowing the majority of sessions to occur remotely.
This program was purposely designed based on investigators' prior research and other significant studies in the field, aiming to overcome common barriers to physical activity in cancer populations. To facilitate participation, the investigators enable exercise at home utilizing the participant's preferred activity (e.g., walking, cycling, stairs) and at convenient times. The majority engaged in walking-based intervention, which despite their simplicity, provided sufficient intensity for deconditioned HCT participants. Others used cycle ergometers. This program adheres to the principles of exercise training and recommendations from Sasso and colleagues, ensuring individualization, progressive overload, appropriate recovery periods, and reasonable specificity. Exercise sessions started with a 5-minute warmup (e.g., walking or cycling at a HR corresponding to 60% VO2peak). This was followed by ten intervals, each consisting of one-minute of high intensity exercise at a HR corresponding to 95% VO2peak, alternated with one minute of low to moderate intensity interval at a HR corresponding to 60% VO2peak, totaling 20 minutes. The session concluded with a 5-minute cooldown, resulting in a comprehensive 30-minutes exercise session. For participants unable to complete all intervals, the study team began with fewer intervals and gradually increased the number as tolerated. A recovery period of 24-48 hours between HIIT sessions was recommended to prevent overtraining and ensure adequate recovery. Broad specificity was achieved by incorporating high, moderate, and low intensity aerobic exercises continuously. As such, the program is a progressive HIIT-based intervention, with flexibility given to ensure the principles of exercise training are upheld, and participants receive the best possible information and guidance to rapidly increase CRF and health outcomes pre-HCT.
The investigators' prior phase 1 study was successful. Out of 24 participants approached, 14 enrolled (10 males, 4 females), achieving a recruitment rate of 58%. Of the 14 enrolled, 13 (age 59±12, range 34-76 yrs; 10 White, 3 Black) were medically cleared to proceed with HIIT following a CPET. One participant did not proceed to HIIT and was withdrawn due to cardiac concerns detected on baseline CPET. Importantly, there were no adverse events associated with exercise among the remaining participants. Participants were able to engage in HIIT, even with a baseline CRF as low as 10.6 mL/kg/min; for reference, independent living in healthy adults is generally associated with a CRF >18 in men and >15 in women. Some participants who were habitually exercising were able to complete ten intervals immediately and to maintain intensity over time, while other participants who were less fit required more coaching but were able to rapidly improve fitness to reach program goals. Remarkably, even with low baseline CRF and concomitant chemotherapy (some requiring hospitalization), nine of the 13 participants engaged in the exercise program (69%), and average adherence to the prescribed 3 sessions/week in those nine was excellent at 104 +/- 28%. Mean intervention length was 13.8 +/- 7.5 weeks, with participants staying engaged in the exercise program for approximately three months prior to HCT; this compares very favorably to the 50-70% adherence rates commonly reported in other home-based exercise studies. All 7 participants who had repeat CPET showed improvements in CRF, with average change in VO2peak from 14.6 ± 3.1 mL/kg/min at enrollment to 17.9 ± 3.3 by the start of transplant, or 23% increase (p<0.001). For the other 6, 3 were not evaluated due to the onset of the COVID-19 pandemic, which suspended research operations. Because CRF declines at about 10% per decade, this substantial improvement in CRF equates to a fitness level increase that typically would take over 20 years to achieve, aligning participants' fitness more closely with that of healthy adults34. As highlighted by Wood et al.,16 a pre-HCT VO2peak <16 mL/kg/min is associated with higher post-HCT mortality rate (HR 6.70 (1.29-34.75), p=0.02) and longer hospital stay (median number of hospitalized days before Day 100: 33 vs. 21, p=0.004). Thus, increasing CRF pre-HCT has the potential to improve post-HCT outcomes, suggesting this program could substantially impact participant health and recovery.
The investigators believe this program's success is from a combination of participant motivation and mHealth platform and coaching. Because participants know that they were to undergo HCT within a few months, with a 10-30% chance of death related to the treatment itself, they were highly motived to do anything they could to improve their chances of survival. Furthermore, knowing that an oncology-experienced exercise professional is monitoring their exercise sessions, coupled with personalized and frequent feedback (at least once a week), likely helped improve adherence, with resultant improvements in CRF.
Allogeneic HCT has curative potential for hematologic malignancies but is associated with significant morbidity and TRM, especially in patients with low pre-HCT CRF. Improving CRF through a time-efficient, high-intensity interval training (HIIT) approach, facilitated remotely via mHealth, could improve physical function and clinical outcomes for HCT patients. The investigators hypothesize that patients undergoing REMM-HIIT program will experience improved CRF, physical function, and QOL pre-HCT, leading to better post-HCT outcomes, including improved physical function, reduced TRM, and increased overall survival.
- Being tested
- High Intensity Interval Training
- Keywords
- High Intensity Interval Training, HIIT, Hematopoietic Stem Cell Transplantation, Remote Monitoring, Mobile Health, Exercise, Cardiorespiratory Fitness
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
High Intensity Interval TrainingBehavioural
The intervention will consist of three 30-minute training sessions/week, each starting with a five-minute warm-up, followed by 20 minutes of interval training, and ending with a five-minute cool-down. The interval training will consist of 10 alternating high- and low-intensity intervals, with a 1:1 work-to-rest ratio (one minute of high intensity followed by one minute of low-moderate intensity). As participants' fitness improves, the interval intensity will increase accordingly.
| Study group | Role | What they receive |
|---|---|---|
| HIIT Group | Experimental | The intervention will consist of three 30-minute training sessions/week, each starting with a five-minute warm-up, followed by 20 minutes of interval training, and ending with a five-minute cool-down. The interval training will consist of 10 alternating high- and low-intensity intervals, with a 1:1 work-to-rest ratio (one minute of high intensity followed by one minute of low-moderate intensity). Receives: Behavioral: High Intensity Interval Training |
| Control Group | No intervention | Participants will receive a handout and information on exercise. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Cardiorespiratory Fitness
Change in cardiorespiratory fitness as measured by the difference in peak rate of oxygen consumption (VO2peak) in mL/(kg*min) from baseline to the pre-hematopoietic stem cell transplant (HCT) timepoint; a higher number for VO2 peak indicates greater cardiorespiratory fitness.
Measured: At Baseline, Day -10, Day 90, and Day 365
Change in Physical Function (Six Minute Walk Test Distance)
The change in physical function as measured by the difference in six minute walk test distance in meters from baseline to the pre-hematopoietic stem cell transplantation (HCT) timepoint; a greater number of meters walked indicates a higher level of physical function.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Secondary outcomes (24)
Effect on Health-related Quality of Life (Physical Activity/Short Physical Performance Battery)
Effect on health-related quality of life (physical activity) as measured by performance on the Short Physical Performance Battery, which results in a score from 0 to 12 points, with a higher number indicating better physical performance.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/30-Second Sit-to-Stand Test)
Effect on health-related qulaity of life (physical activity) as measured by the 30-second sit-to-stand test, which measures the number of times an individual can stand up from a chair and sit back down within 30 seconds, with a higher number indicating greater fitness.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Fried Frailty)
Effect on health-related quality of life (physical activity) as measured by the Fried Frailty assessment, which results in a score from 0 to 5, with a higher number indicating greater frailty.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Fall Question)
Effect on health-related quality of life (physical activity) as measured by the Fall Question, a structured questionnaire asking about any history of falls, with a higher number of falls indicating greater fall risk and physical vulnerability.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Physical Function Questionnaire)
Effect on health-related quality of life (physical activity) as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function questionnaire, which results in a numerical score between 0 and 100, with a higher number indicating better physical function.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Fatigue Questionnaire)
Effect on health-related quality of life (physical activity) as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue questionnaire, which results in a numerical score between 0 and 100, with a higher number indicating greater symptom burden.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/International Physical Activity Questionnaire)
Effect on health-related quality of life (physical activity) as measured by the International Physical Activity Questionnaire, which provides 2 results: a categorical rating of low, moderate, or high activity level, and a number of Metabolic Equivalent of Task (MET) minutes per week, with a higher number indicating a greater amount of physical activity.
Measured: At Baseline
Effect on Health-related Quality of Life (Cognitive/Montreal Cognitive Assessment)
Effect on health-related quality of life (cognitive) as measured by the Montreal Cognitive Assessment (MOCA), which results in a numerical score between 0 and 30, with a higher number indicating better cognitive functioning.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Mental Health/Lorig Self-Efficacy)
Effect on health-related quality of life (mental health) as measured by the Lorig Self-Efficacy for Managing Chronic Disease Scale, which results in a numerical score between 1 and 10, with a higher number indicating higher self-efficacy.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Mental Health/Depression Scale)
Effect on health-related quality of life (mental health) as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression scale, which results in a numerical value between 8 and 40, with a higher number indicating greater severity of depression.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Mental Health/Anxiety scale)
Effect on health-related quality of life (mental health) as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety scale, which results in a numerical value between 7 and 35, with a higher number indicating greater severity of anxiety.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Weight)
Effect on health-related quality of life (weight) as measured by the change in patient's body weight in kilograms.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Albumin Level)
Effect on health-related quality of life (albumin level) as measured by the change in patient's albumin level in grams per deciliter; low serum albumin levels can predict higher cancer mortality.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Nutrition)
Effect on health-related quality of life (nutrition) as measured by the Patient-Generated Subjective Global Assessment (PG-SGA), which gives 2 results: a numerical score between 0 and 16, where a higher score indicates higher nutritional risk, and a categorical score where A = well nourished, B = moderately malnourished, and C = severely malnourished.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Social Support/Emotional Support)
Effect on health-related quality of life (social support) as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Support assessment, which results in a numerical score between 8 and 40, with a higher score indicating a greater level of social participation.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Social Support/Social Isolation)
Effect on health-related quality of life (social support) as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation assessment, which results in a numerical score between 6 and 30, with a higher score indicating a greater level of social participation.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (EuroQoL-5 Dimension-5 Level)
Effect on health-related quality of life as measured by the EuroQoL-5 Dimension-5 Level (EQ-5D-5L), which results in a 5-digit health state, where each digit is between 1 and 5 (e.g. 12345 or 11111). For each digit, a higher number indicates a greater severity of problems.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Return to Work)
Effect on health-related quality of life as measured by assessing the patient's return to work as an indicator of recovery.
Measured: At Day 180 and Day 365
Effect on Clinical Outcomes (Overall Survival)
Effect on clinical outcomes as measured by overall survival.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Treatment-related Mortality)
Effect on clinical outcomes as measured by treatment-related mortality.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Incidence of Infection)
Effect on clinical outcomes as measured by incidence of infection.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Incidence of Graft-versus-host disease)
Effect on clinical outcomes as measured by incidence of graft versus host disease.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Time to Relapse)
Effect on clinical outcomes as measured by time to relapse.
Measured: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Length of Stay
The length of hospital stay measured in days from time of transplant to time of discharge.
Measured: At day of hospital discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2025
- Study startMay 2025 (estimated)
- Primary completionOct 2028 (estimated)
- Study completionMar 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (147)Papers the sponsor has linked to this study.
- Other trials for Hematopoietic Stem Cell TransplantationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 126 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Kansas Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Anthony Sung, MD, Principal investigator, The University of Kansas Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06953648
- Sponsor's protocol ID
- REMM-HIIT
- Acronym
- REMM-HIIT
- Status last verified
- Apr 2025
- First submitted
- 26 Mar 2025
- Last updated
- 1 May 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
McCulloch CE, Neuhaus JM. Generalized Linear Mixed Models. Encyclopedia of Biostatistics2005
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63. doi: 10.1038/nature12820. Epub 2013 Dec 11.
PubMed 24336217David LA, Weil A, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ. Gut microbial succession follows acute secretory diarrhea in humans. mBio. 2015 May 19;6(3):e00381-15. doi: 10.1128/mBio.00381-15.
PubMed 25991682Thompson JC, Ren Y, Romero K, Lew M, Bush AT, Messina JA, Jung SH, Siamakpour-Reihani S, Miller J, Jenq RR, Peled JU, van den Brink MRM, Chao NJ, Shrime MG, Sung AD. Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients. PLoS One. 2022 May 4;17(5):e0267974. doi: 10.1371/journal.pone.0267974. eCollection 2022.
PubMed 35507633Team RC. R: A language and environment for statistical computing Vienna, Austria2014.
Xie Y. Dynamic Documents with R and knitr. Chapman & Hall/CRC The R Series. Boca Raton, FL: Chapman & Hall/CRC 2013.
LIANG K-Y, ZEGER SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22. doi: 10.1093/biomet/73.1.13.
Jung SH, Ahn C. Sample size estimation for GEE method for comparing slopes in repeated measurements data. Stat Med. 2003 Apr 30;22(8):1305-15. doi: 10.1002/sim.1384.
PubMed 12687656Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. doi: 10.1186/gb-2004-5-10-r80. Epub 2004 Sep 15.
PubMed 15461798Huffman KM, Jessee R, Andonian B, Davis BN, Narowski R, Huebner JL, Kraus VB, McCracken J, Gilmore BF, Tune KN, Campbell M, Koves TR, Muoio DM, Hubal MJ, Kraus WE. Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability. Arthritis Res Ther. 2017 Jan 23;19(1):12. doi: 10.1186/s13075-016-1215-7.
PubMed 28114971Huffman KM, Koves TR, Hubal MJ, Abouassi H, Beri N, Bateman LA, Stevens RD, Ilkayeva OR, Hoffman EP, Muoio DM, Kraus WE. Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness. Diabetologia. 2014 Nov;57(11):2282-95. doi: 10.1007/s00125-014-3343-4. Epub 2014 Aug 5.
PubMed 25091629Metzger KE, Rucker Y, Callaghan M, Churchill M, Jovanovic BD, Zembower TR, Bolon MK. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients. Infect Control Hosp Epidemiol. 2015 Feb;36(2):119-24. doi: 10.1017/ice.2014.38.
PubMed 25632993Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales MA, Lindemans CA, Komanduri KV, Riches ML. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. JAMA Netw Open. 2020 Jan 3;3(1):e1918668. doi: 10.1001/jamanetworkopen.2019.18668.
PubMed 31913492Sung AD, Chao NJ. Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment. Stem Cells Transl Med. 2013 Jan;2(1):25-32. doi: 10.5966/sctm.2012-0115. Epub 2012 Dec 19.
PubMed 23283494Campbell SC, Wisniewski PJ, Noji M, McGuinness LR, Haggblom MM, Lightfoot SA, Joseph LB, Kerkhof LJ. The Effect of Diet and Exercise on Intestinal Integrity and Microbial Diversity in Mice. PLoS One. 2016 Mar 8;11(3):e0150502. doi: 10.1371/journal.pone.0150502. eCollection 2016.
PubMed 26954359
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)
- ClinicalTrials.gov ID
- NCT06953648
- Acronym / sponsor ID
- REMM-HIIT / REMM-HIIT
- Keywords
- High Intensity Interval Training, HIIT, Hematopoietic Stem Cell Transplantation, Remote Monitoring, Mobile Health, Exercise, Cardiorespiratory Fitness
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 126 participants (estimated)
- Lead sponsor
- University of Kansas Medical CenterUniversity, hospital or other
- Study start
- May 2025 (estimated)
- Primary completion
- Oct 2028 (estimated)
- Study completion
- Mar 2030 (estimated)
- First posted
- 1 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and physical function for patients planning to undergo stem cell transplantation. The main questions it aims to answer are:
Is there a change in the participant's cardiorespiratory fitness level? Is there a change in the participant's physical function?
Researchers will compare the REMM-HIIT program to a control group of participants who do not take part in the training program to see if REMM-HIIT helps improve stem cell transplantation outcomes.
Participants will:
- Complete cardiopulmonary exercise testing (CPET) 4 times during the study
- Do basic tests to measure physical function 6 times during the study
- Answer questions about their life and how they are feeling 6 times during the study
- Wear a device to keep track of step counts and heart rate daily
- Keep a log of every time they exercise throughout the study
- Optionally, provide blood and stool samples 6 times during the study
Detailed description
Each year in the U.S., approximately 8,000 patients undergo allogeneic hematopoietic stem cell transplantation (HCT) as a potentially curative therapy for leukemias, lymphomas, and other hematologic malignancies. However, treatment-related mortality (TRM) is significant, ranging from 10-30%. Moreover, survivors of HCT often face significant physical, psychological, and social challenges post-treatment, leading to a substantial decrease in quality of life (QOL). Outcomes are closely linked to pre-HCT physical activity and function. For example, patients with worse pre-HCT physical function and capacity have markedly lower one-year survival rates (50% vs. 83%). In contrast, every 50-meter increase in pre-HCT six-minute walk distance (6MWD) correlates with a 9% reduction in relative risk for mortality.
Cardiorespiratory fitness (CRF) is a crucial indicator of physical capacity, reflecting the integrated functioning of the heart, lungs, skeletal muscle, adipose tissue, pancreas, liver and adrenal tissues. While CRF naturally declines with age, this decline is notably accelerated by cancer and its treatments, with cancer patients' average CRF levels comparable to individuals 20-30 years older. Importantly, patients with low pre-HCT CRF (VO2peak <16 mL/kg/min) are at much higher risk of TRM (hazard ratio 6.70), even after accounting for other risk factors. This underscores the critical need for interventions to improve CRF prior to HCT to enhance survival and post-treatment quality of life.
It is well established that patients with better pre-HCT physical function tend to have better post-HCT outcomes. The critical question, however, is whether enhancing fitness pre-HCT can improve post-HCT outcomes. Animal studies provide optimism: exercise training in a murine model pre-HCT associated with improved survival, possibly through immune-mediated pathways. Yet, research exploring the impact of pre-HCT exercise on human post-HCT outcomes remains limited. Small studies have linked pre-HCT improvements in physical function with better survival, and preliminary results from a randomized controlled trial suggest that exercise during HCT may reduce mortality. However, a recent large (n=711) randomized Blood and Marrow Transplant Clinical Trials Network study of self-directed exercise and stress management during HCT did not show a significant benefit in outcomes. Study investigators suggested several reasons for this lack of effect, including timing of intervention (peri-HCT rather than pre-HCT), low intensity rather than high intensity exercise, and low engagement in the self-directed program.
To address prior study limitations, the investigators developed the REMM-HIIT program, focusing on pre-HCT intervention, high-intensity interval training (HIIT), and a mobile health (mHealth) platform to support participant engagement. This program, supported by the National Institute of Aging and the Duke Claude D. Pepper Older Americans Independence Center, was piloted in a successful phase 1 study of Remotely Monitored, Mobile health-supported, pre-HCT High Intensity Interval Training (REMM-HIIT). In this feasibility study, participants underwent baseline cardiopulmonary exercise testing (CPET) to ensure cardiac safety and to measure maximal cardiorespiratory fitness (VO2peak). The heart rate (HR) at VO2peak was used to personalize the high and low intensity interval goals. Participants were equipped with an iPhone and Garmin Watch for remote monitoring and exercised three times a week at home, with the first session and subsequent sessions as needed monitored remotely by the coach via videoconference. This approach ensured continuous support and maximized participant engagement while allowing the majority of sessions to occur remotely.
This program was purposely designed based on investigators' prior research and other significant studies in the field, aiming to overcome common barriers to physical activity in cancer populations. To facilitate participation, the investigators enable exercise at home utilizing the participant's preferred activity (e.g., walking, cycling, stairs) and at convenient times. The majority engaged in walking-based intervention, which despite their simplicity, provided sufficient intensity for deconditioned HCT participants. Others used cycle ergometers. This program adheres to the principles of exercise training and recommendations from Sasso and colleagues, ensuring individualization, progressive overload, appropriate recovery periods, and reasonable specificity. Exercise sessions started with a 5-minute warmup (e.g., walking or cycling at a HR corresponding to 60% VO2peak). This was followed by ten intervals, each consisting of one-minute of high intensity exercise at a HR corresponding to 95% VO2peak, alternated with one minute of low to moderate intensity interval at a HR corresponding to 60% VO2peak, totaling 20 minutes. The session concluded with a 5-minute cooldown, resulting in a comprehensive 30-minutes exercise session. For participants unable to complete all intervals, the study team began with fewer intervals and gradually increased the number as tolerated. A recovery period of 24-48 hours between HIIT sessions was recommended to prevent overtraining and ensure adequate recovery. Broad specificity was achieved by incorporating high, moderate, and low intensity aerobic exercises continuously. As such, the program is a progressive HIIT-based intervention, with flexibility given to ensure the principles of exercise training are upheld, and participants receive the best possible information and guidance to rapidly increase CRF and health outcomes pre-HCT.
The investigators' prior phase 1 study was successful. Out of 24 participants approached, 14 enrolled (10 males, 4 females), achieving a recruitment rate of 58%. Of the 14 enrolled, 13 (age 59±12, range 34-76 yrs; 10 White, 3 Black) were medically cleared to proceed with HIIT following a CPET. One participant did not proceed to HIIT and was withdrawn due to cardiac concerns detected on baseline CPET. Importantly, there were no adverse events associated with exercise among the remaining participants. Participants were able to engage in HIIT, even with a baseline CRF as low as 10.6 mL/kg/min; for reference, independent living in healthy adults is generally associated with a CRF >18 in men and >15 in women. Some participants who were habitually exercising were able to complete ten intervals immediately and to maintain intensity over time, while other participants who were less fit required more coaching but were able to rapidly improve fitness to reach program goals. Remarkably, even with low baseline CRF and concomitant chemotherapy (some requiring hospitalization), nine of the 13 participants engaged in the exercise program (69%), and average adherence to the prescribed 3 sessions/week in those nine was excellent at 104 +/- 28%. Mean intervention length was 13.8 +/- 7.5 weeks, with participants staying engaged in the exercise program for approximately three months prior to HCT; this compares very favorably to the 50-70% adherence rates commonly reported in other home-based exercise studies. All 7 participants who had repeat CPET showed improvements in CRF, with average change in VO2peak from 14.6 ± 3.1 mL/kg/min at enrollment to 17.9 ± 3.3 by the start of transplant, or 23% increase (p<0.001). For the other 6, 3 were not evaluated due to the onset of the COVID-19 pandemic, which suspended research operations. Because CRF declines at about 10% per decade, this substantial improvement in CRF equates to a fitness level increase that typically would take over 20 years to achieve, aligning participants' fitness more closely with that of healthy adults34. As highlighted by Wood et al.,16 a pre-HCT VO2peak <16 mL/kg/min is associated with higher post-HCT mortality rate (HR 6.70 (1.29-34.75), p=0.02) and longer hospital stay (median number of hospitalized days before Day 100: 33 vs. 21, p=0.004). Thus, increasing CRF pre-HCT has the potential to improve post-HCT outcomes, suggesting this program could substantially impact participant health and recovery.
The investigators believe this program's success is from a combination of participant motivation and mHealth platform and coaching. Because participants know that they were to undergo HCT within a few months, with a 10-30% chance of death related to the treatment itself, they were highly motived to do anything they could to improve their chances of survival. Furthermore, knowing that an oncology-experienced exercise professional is monitoring their exercise sessions, coupled with personalized and frequent feedback (at least once a week), likely helped improve adherence, with resultant improvements in CRF.
Allogeneic HCT has curative potential for hematologic malignancies but is associated with significant morbidity and TRM, especially in patients with low pre-HCT CRF. Improving CRF through a time-efficient, high-intensity interval training (HIIT) approach, facilitated remotely via mHealth, could improve physical function and clinical outcomes for HCT patients. The investigators hypothesize that patients undergoing REMM-HIIT program will experience improved CRF, physical function, and QOL pre-HCT, leading to better post-HCT outcomes, including improved physical function, reduced TRM, and increased overall survival.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| HIIT Group | Experimental | Behavioral: High Intensity Interval TrainingThe intervention will consist of three 30-minute training sessions/week, each starting with a five-minute warm-up, followed by 20 minutes of interval training, and ending with a five-minute cool-down. The interval training will consist of 10 alternating high- and low-intensity intervals, with a 1:1 work-to-rest ratio (one minute of high intensity followed by one minute of low-moderate intensity). |
| Control Group | No intervention | –Participants will receive a handout and information on exercise. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Plan to undergo allogeneic hematopoietic stem cell transplant in 4-12 weeks after enrollment on this study.
- Age 18-80 years
- Able to read/write English (as many participant-reported outcome measures lack validated translations in other languages)
Key exclusion criteria (11 listed)
- Unable or unwilling to follow coaching
- Functional impairment resulting in inability to exercise
- Any absolute contraindications to exercise:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| High Intensity Interval TrainingThe intervention will consist of three 30-minute training sessions/week, each starting with a five-minute warm-up, followed by 20 minutes of interval training, and ending with a five-minute cool-down. The interval training will consist of 10 alternating high- and low-intensity intervals, with a 1:1 work-to-rest ratio (one minute of high intensity followed by one minute of low-moderate intensity). As participants' fitness improves, the interval intensity will increase accordingly. | Behavioural | HIIT Group |
Primary outcome
Change in Cardiorespiratory Fitness
Time frame: At Baseline, Day -10, Day 90, and Day 365
Change in cardiorespiratory fitness as measured by the difference in peak rate of oxygen consumption (VO2peak) in mL/(kg*min) from baseline to the pre-hematopoietic stem cell transplant (HCT) timepoint; a higher number for VO2 peak indicates greater cardiorespiratory fitness.
Change in Physical Function (Six Minute Walk Test Distance)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
The change in physical function as measured by the difference in six minute walk test distance in meters from baseline to the pre-hematopoietic stem cell transplantation (HCT) timepoint; a greater number of meters walked indicates a higher level of physical function.
24 secondary outcomes
Effect on Health-related Quality of Life (Physical Activity/Short Physical Performance Battery)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/30-Second Sit-to-Stand Test)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Fried Frailty)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Fall Question)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Physical Function Questionnaire)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/Fatigue Questionnaire)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Physical Activity/International Physical Activity Questionnaire)
Time frame: At Baseline
Effect on Health-related Quality of Life (Cognitive/Montreal Cognitive Assessment)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Mental Health/Lorig Self-Efficacy)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Mental Health/Depression Scale)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Mental Health/Anxiety scale)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Weight)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Albumin Level)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Nutrition)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Social Support/Emotional Support)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Social Support/Social Isolation)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (EuroQoL-5 Dimension-5 Level)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Health-related Quality of Life (Return to Work)
Time frame: At Day 180 and Day 365
Effect on Clinical Outcomes (Overall Survival)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Treatment-related Mortality)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Incidence of Infection)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Incidence of Graft-versus-host disease)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Effect on Clinical Outcomes (Time to Relapse)
Time frame: At Baseline, Day -10, Day 30, Day 90, Day 180, and Day 365
Length of Stay
Time frame: At day of hospital discharge
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2025.
- BackgroundMcCulloch CE, Neuhaus JM. Generalized Linear Mixed Models. Encyclopedia of Biostatistics2005
- Background: PubMed 24336217David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63. doi: 10.1038/nature12820. Epub 2013 Dec 11.
- Background: PubMed 25991682David LA, Weil A, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ. Gut microbial succession follows acute secretory diarrhea in humans. mBio. 2015 May 19;6(3):e00381-15. doi: 10.1128/mBio.00381-15.
- Background: PubMed 35507633Thompson JC, Ren Y, Romero K, Lew M, Bush AT, Messina JA, Jung SH, Siamakpour-Reihani S, Miller J, Jenq RR, Peled JU, van den Brink MRM, Chao NJ, Shrime MG, Sung AD. Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients. PLoS One. 2022 May 4;17(5):e0267974. doi: 10.1371/journal.pone.0267974. eCollection 2022.
- BackgroundTeam RC. R: A language and environment for statistical computing Vienna, Austria2014.
- BackgroundXie Y. Dynamic Documents with R and knitr. Chapman & Hall/CRC The R Series. Boca Raton, FL: Chapman & Hall/CRC 2013.
- BackgroundLIANG K-Y, ZEGER SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22. doi: 10.1093/biomet/73.1.13.
- Background: PubMed 12687656Jung SH, Ahn C. Sample size estimation for GEE method for comparing slopes in repeated measurements data. Stat Med. 2003 Apr 30;22(8):1305-15. doi: 10.1002/sim.1384.
- Background: PubMed 15461798Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. doi: 10.1186/gb-2004-5-10-r80. Epub 2004 Sep 15.
- Background: PubMed 28114971Huffman KM, Jessee R, Andonian B, Davis BN, Narowski R, Huebner JL, Kraus VB, McCracken J, Gilmore BF, Tune KN, Campbell M, Koves TR, Muoio DM, Hubal MJ, Kraus WE. Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability. Arthritis Res Ther. 2017 Jan 23;19(1):12. doi: 10.1186/s13075-016-1215-7.
- Background: PubMed 25091629Huffman KM, Koves TR, Hubal MJ, Abouassi H, Beri N, Bateman LA, Stevens RD, Ilkayeva OR, Hoffman EP, Muoio DM, Kraus WE. Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness. Diabetologia. 2014 Nov;57(11):2282-95. doi: 10.1007/s00125-014-3343-4. Epub 2014 Aug 5.
- Background: PubMed 25632993Metzger KE, Rucker Y, Callaghan M, Churchill M, Jovanovic BD, Zembower TR, Bolon MK. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients. Infect Control Hosp Epidemiol. 2015 Feb;36(2):119-24. doi: 10.1017/ice.2014.38.
- Individual participant dataSharing planned: No
Related trials for Hematopoietic Stem Cell Transplantation
Not yet recruitingPhase 1
Expanded Donor Stem Cells for Poor Graft Function After Stem Cell Transplantation in Children
Poor Graft Function, Hematopoietic Stem Cell Transplantation Complications
Not yet recruiting
Impact of Closed PBSC Collection With Reduced Gas-Phase Oxygen Exposure on Graft Quality and Early Engraftment in Allo-HSCT
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Oxygen Deficiency
Not yet recruiting
MAC vs RIC for Transplantation in FLT3-ITD-Mutated AML Guided by UHS-NGS MRD ( FLT3 - MAC vs RIC )
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia
RecruitingObservational study
Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy
Cellular Immunotherapy, Adoptive, Genetic Therapy
Recruiting
Comprehensive Palliative Care After Stem Cell Transplantation: a Feasability Study
Hematopoietic Stem Cell Transplantation (HSCT)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Anthony Sung, MD principal investigator
The University of Kansas Cancer Center
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing High Intensity Interval Training in people with Hematopoietic Stem Cell Transplantation and Cardiorespiratory Fitness, run by University of Kansas Medical Center at 3 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Anthony Sung (913-588-6030, asung2@kumc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Cardiorespiratory Fitness (time frame: At Baseline, Day -10, Day 90, and Day 365). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06953648, which also lists 147 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025; AzTrials last refreshed its copy on 1 Nov 2026.